Pharmacology of anti-anxiety drugs with special reference to clobazam
about
Isolation of clobazam-orosomucoid complexes from patients' sera.Clobazam: pharmacological and therapeutic profile.Current status of the 1,4- and 1,5-benzodiazepines in the treatment of epilepsy: the place of clobazam.Effects of clobazam and its active metabolite on GABA-activated currents in rat cerebral neurons in culture.N-desmethylclobazam: a possible alternative to clobazam in the treatment of refractory epilepsy?Interactions of clobazam with conventional antiepileptics in children.Single dose pharmacokinetic study of clobazam in normal volunteers and epileptic patients.HPLC method for simultaneous determination of clobazam and N-desmethylclobazam in human serum, rat serum and rat brain homogenates.Clobazam in therapy-resistant patients with partial epilepsy: a double-blind placebo-controlled crossover study.Clobazam for treatment of epilepsy.Clobazam for patients with Lennox-Gastaut syndrome and epilepsy.Clobazam: anticonvulsant action in animal models of epilepsy [proceedings]Antileptazol activity and kinetic of CP 1414 S (7-nitro-2-amino-5-phenyl-3-H-,1,5-benzodiazepine-4-one) in the rat and mouse.Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes.Impact of CYP2C19 polymorphisms on the efficacy of clobazam therapy.Up-regulation of L-type high voltage-gated calcium channel subunits by sustained exposure to 1,4- and 1,5-benzodiazepines in cerebrocortical neurons.Plasma concentrations of clobazam and its N-desmethyl metabolite; protection against pentetrazol-induced convulsions in mice.Clobazam in Treatment of Refractory Epilepsy: The Canadian Experience. A RetrospectiEffect of CYP2C19 polymorphisms on the clinical outcome of low-dose clobazam therapy in Japanese patients with epilepsyCommunications
P2860
Q31162623-8A6DF56B-BEA0-432B-96A9-522A876756A2Q34181843-51024144-EF44-4342-B6E7-C01293BE9C73Q34182386-CBFD5EDB-EA20-43D5-AE26-9636EF226834Q34393183-5F86A40E-876D-440C-9600-43E6067B123DQ34416248-1715608D-4EFB-4E81-A20D-B566E50D03A1Q34424215-C92D066C-E0AF-41FB-8AC6-331FA0B2F54CQ34622098-6962BA44-943E-48CB-9CFC-55470D66324CQ36065173-A4C65AF6-465F-4C72-8154-FADFC3D2BADEQ36432289-5AE40290-0867-4883-8170-3625E2FE2903Q37975516-B21B3783-6F8C-40EA-BCB3-0A2F0BAE5D51Q37997090-A813ECB8-19E3-4787-8DFE-E52F531D778CQ39246669-F6687879-BFF5-4515-93D3-B2A275907634Q42264876-AACD49B0-19CA-49B0-A430-4B96D9FA5CB5Q42640209-968C2780-6786-416B-91C9-F8F6206AEB7DQ46605318-2C71E1CF-4A21-49FA-AC4B-2FDC9C37D778Q46941023-86E17740-403A-4232-B379-D6BD4E591AA0Q49173520-333CD727-2222-48A2-97D5-8220A83E6C1BQ56805040-1A8C8642-B706-4FA2-B882-FEE11EF01033Q57770173-B534E14D-8314-4DCE-89DC-77E48158C506Q58830771-7796772D-90F2-4B69-A037-0A74DE348F88
P2860
Pharmacology of anti-anxiety drugs with special reference to clobazam
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年学术文章
@wuu
1979年学术文章
@zh-cn
1979年学术文章
@zh-hans
1979年学术文章
@zh-my
1979年学术文章
@zh-sg
1979年學術文章
@yue
1979年學術文章
@zh
1979年學術文章
@zh-hant
name
Pharmacology of anti-anxiety drugs with special reference to clobazam
@en
Pharmacology of anti-anxiety drugs with special reference to clobazam.
@nl
type
label
Pharmacology of anti-anxiety drugs with special reference to clobazam
@en
Pharmacology of anti-anxiety drugs with special reference to clobazam.
@nl
prefLabel
Pharmacology of anti-anxiety drugs with special reference to clobazam
@en
Pharmacology of anti-anxiety drugs with special reference to clobazam.
@nl
P1476
Pharmacology of anti-anxiety drugs with special reference to clobazam
@en
P2093
Fielding S
Hoffmann I
P2860
P304
P356
10.1111/J.1365-2125.1979.TB05920.X
P407
P478
P577
1979-01-01T00:00:00Z